TokenPost·
UnitedHealthcare Lists Amvuttra as Nonpreferred in Medicare Policy
The policy took effect Oct. 1 for certain Medicare Advantage drug plans. Amvuttra revenue rose 65% year over year to $1.13 billion in the third quarter.
More news
- Crypto BriefingNorth Korea denies involvement in $6.3B Binance hack, calls FBI claims absurd
- TokenPostQodo Brings Company Coding Standards to Codex Code Review
- TokenPostNEAR Protocol Extends Crypto Losses With an 8.89% Drop to $3.89
- TokenPostZcash Co-Founder Says Privacy Tool Was Used in Coinholder Vote
- TokenPostUSDC Treasury Mints $250 Million in USD Coin
- TokenPostPepe (PEPE) Trading Volume Tops Shiba Inu (SHIB) by 16.4 Times